Skip to main content
SpringerLink
Log in
Book cover

Immunotoxicity Testing pp 3–13Cite as

Immunotoxicology: A Brief History

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1803))

Abstract

Immunotoxicological research and testing have evolved from early studies of anaphylaxis to the robust and diverse field of immunotoxicology as we know it today. Early studies connecting immune dysfunction with exposure to exogenous agents focused on adverse reactions to immunogenic agents present in vaccines. Over time, work done by immunologists and pathologists leads to descriptions of characteristics of immunogenic agents as well as mechanisms by which anaphylaxis occurs and an understanding of the concept of immunosuppression. These myriad achievements greatly improved public health and led the field of immunotoxicology, which addresses all aspects of adverse immunological responses following exposure to exogenous agents as well as the development of testing paradigms to understand immunological responses of designed agents such as drugs and biologics.

This is a preview of subscription content, log in via an institution.

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Junod SW (2009) Biologics centennial: 100 years of biologics regulation. https://www.fda.gov/AboutFDA/WhatWeDo/History/ProductRegulation/SelectionsFromFDLIUpdateSeriesonFDAHistory/ucm091754.htm

  2. Von Pirquet C, Schick B (1906) Serum sickness. München Med Wchnshr 53:1457

    Google Scholar 

  3. Portier P, Richet C (1902) De l’action anaphylactique de certains venins. CR Séances Soc Bio 54:170

    Google Scholar 

  4. Auer J (1911) Lethal cardiac anaphylaxis in the rabbit. J Exp Med 14:476–496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Feinberg SM, Feinberg AR, Moran CF (1953) Penicillin anaphylaxis, nonfatal and fatal reactions. J Am Med Assoc 152:114–119

    Article  CAS  PubMed  Google Scholar 

  6. Solensky R (2003) Hypersensitivity reactions to betalactamantibiotics. Clin Rev Allergy Immunol 24:201–220

    Article  CAS  PubMed  Google Scholar 

  7. Landsteiner K, Jacobs J (1935) Studies on the sensitization of animals with simple chemical compounds. J Exp Med 61:643–656

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Landsteiner K, Jacobs J (1936) Studies on the sensitization of animals with simple chemical compounds. J Exp Med 64:625–639

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Levine BB (1964) Studies on the immunological mechanisms of penicillin allergy. I. Antigenic specificities of Guinea-pig skin sensitizing rabbit anti-benzylpenicillin antibodies. Immunology 7:527–541

    PubMed  PubMed Central  CAS  Google Scholar 

  10. Ovary Z, Benacerraf B, Bloch KJ (1963) Properties of Guinea pig 7S antibodies. II. Identification of antibodies involved in passive cutaneous and systemic anaphylaxis. J Exp Med 117:951–964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Ovary Z (1958) Passive cutaneous anaphylaxis in the mouse. J Immunol 81:355–357

    PubMed  CAS  Google Scholar 

  12. Dearman RJ, Stone S, Caddick HT, Basketter DA, Kimber I (2003) Evaluation of protein allergenic potential in mice: dose-response analyses. Clin Exp Allergy 33:1586–1594

    Article  CAS  PubMed  Google Scholar 

  13. Draize JH, Woodard G, Calvery HD (1944) Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 83:377–390

    Google Scholar 

  14. Gell PGH, Coombs RRA (1963) Clinical aspects of immunology, 1st edn. Oxford, Blackwell

    Google Scholar 

  15. Ishizaka K, Ishizaka T (1967) Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol 99:1187–1198

    PubMed  CAS  Google Scholar 

  16. Lehrer SB, Vaughan JH (1976) Properties of mouse homocytotropic and heterocytotropic antibodies. J Allergy Clin Immunol 57:422–429

    Article  CAS  PubMed  Google Scholar 

  17. Nydegger UE, Lambert PH, Gerber H, Miescher PA (1974) Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest 54:297–309

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Vos JC (1977) Immune suppression as related to toxicology. Crit Rev Toxicol 5:67–101

    Article  CAS  Google Scholar 

  19. Auerbach C (1958) Mutagenic effects of alkylating agents. Ann N Y Acad Sci 68:731–748

    Article  CAS  PubMed  Google Scholar 

  20. Luster MI, Blank JA, Dean JH (1987) Molecular and cellular basis of chemically induced immunotoxicity. Annu Rev Pharmacol Toxicol 27:23–49

    Article  CAS  PubMed  Google Scholar 

  21. Wara WM (1977) Immunosuppression associated with radiation therapy. Int J Radiat Oncol Biol Phys 2:593–596

    Article  CAS  PubMed  Google Scholar 

  22. Biagini RE (1998) Epidemiology studies in immunotoxicity evaluations. Toxicology 129:37–54

    Article  CAS  PubMed  Google Scholar 

  23. Levitt SH, O’Foghludha FT, Royster RL, Wolf JS, Lower RR, De Giorgi LS (1971) Radiation for immunosuppression in human organ transplantation. I. Experimental data. Acta Radiol Ther Phys Biol 10:248–256

    Article  CAS  PubMed  Google Scholar 

  24. Starzl TE, Halgrimson CG, Penn I, Martineau G, Schroter G, Amemiya H, Putnam CW, Groth CG (1971) Cyclophosphamide and human organ transplantation. Lancet 2:70–74

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Murray JE, Merrill JP, Harrison JH, Wilson RE, Dammin GJ (1963) Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N Engl J Med 268:1315–1323

    Article  CAS  PubMed  Google Scholar 

  26. Squifflet J-P (2011) The history of kidney transplantation: past, present, and future. In: Understanding the complexities of kidney transplantation. Intech, Croatia, pp 3–40

    Google Scholar 

  27. Shubin H, Lambert RE, Ca H, Sokmensuer A, Glaskin A (1959) Steroid therapy and tuberculosis. J Am Med Assoc 170:1885–1890

    Article  CAS  PubMed  Google Scholar 

  28. Bekesi JG, Holland JF, Anderson HA, Fischbein AS, Rom W, Wolff MS, Selikoff IJ (1978) Lymphocyte function of Michigan dairy farmers exposed to polybrominated biphenyls. Science 1999:1207–1209

    Article  Google Scholar 

  29. Thaxton JP, Tung HT, Hamilton PB (1974) Immunosuppression in chickens by aflatoxin. Poult Sci 53:721–725

    Article  CAS  PubMed  Google Scholar 

  30. Nakata H, Sakakibrar A, Kanoh M, Kudo S, Watanabe H, Nagai N, Miyazaki N, Asano Y, Tanabe S (2002) Evaluation of mitogen-induced responses in marine mammal and human lymphocytes by in-vitro exposure of butyltins and non-ortho coplanar PCBs. Eviron Pollut 120:245–253

    Article  CAS  Google Scholar 

  31. House RV, Luebke RW (2007) Immunotoxicology: thirty years and counting. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and immunopharmacology, 3rd edn. CRC Press, Taylor & Francis Group, Boca Raton, FL, pp 3–20

    Google Scholar 

  32. Irey NS (1978) Drug adverse reaction reports related to immunotoxicity. In: Asher IM (ed) Inadvertent modification of the immune response: the effects of foods, drugs, and environmental contaminants. US Food and Drug Administration, Washington, DC, pp 140–143

    Google Scholar 

  33. Berlin A, Dean J, Draper M, Smith EMB, Spreafico F (1987) Synopsis, conclusions, and recommendations. In: Berlin A, Dean J, Draper M, Smith EMB, Spreafico F (eds) Immunotoxicology. Martinus Nijhoff, Dordrecht, pp xi–xxvii

    Google Scholar 

  34. Jerne NK, Nordin AA (1963) Plaque formation in agar by single antibody-producing cells. Science 140:405

    Article  PubMed  Google Scholar 

  35. Burleson GR, Burleson FG (2008) Testing human biologicals in animal host resistance models. J Immunotoxicol 5:23–31

    Article  PubMed  Google Scholar 

  36. Luster MI, Munson AE, Thomas PT, Holsapple MP, Fenters JD, White KL Jr, Lauer LD, Germolec DR, Rosenthal GJ, Dean JH (1988) Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fundam Appl Toxicol 10:2–19

    Article  CAS  PubMed  Google Scholar 

  37. Luster MI, Portier C, Pait DC, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W et al (1993) Risk assessment in immunotoxicology. II Relationships between immune and host resistance tests. Fundam Appl Toxicol 21:71–82

    Article  CAS  PubMed  Google Scholar 

  38. Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ (1992) Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200–210

    Article  CAS  PubMed  Google Scholar 

  39. van der Laan JW, van Loveren H, Vos JG, Dean JH, Hastings KL (1997) Immunotoxicity of pharmaceuticals: current knowledge, testing strategies, risk evaluation, and consequences for human health. Drug Inf J 31:1301–1305

    Article  Google Scholar 

  40. Hastings KL, Nakamura K (2007) Immunotoxicity hazard identification and testing guidelines. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and immunopharmacology, 3rd edn. CRC Press, Taylor & Francis Group, Boca Raton, FL, pp 21–34

    Google Scholar 

  41. US EPA (1996) Health effects test guidelines. OPPTS 870.7800 Immunotoxicity. EPA 712-C-96-351

    Google Scholar 

  42. US EPA (2003) Health effects test guidelines. OPPS 870.2600 Skin sensitization. EPA-712-03-351

    Google Scholar 

  43. ICH (2005) International conference on harmonization of technical requirements for registration of pharmaceuticals for human use. Immunotoxicity studies for human pharmaceuticals. p. S8

    Google Scholar 

  44. Hinton DM (2000) US FDA “Redbook II” immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins. Toxicol Pathol 28:467–478

    Article  CAS  PubMed  Google Scholar 

  45. US FDA (1999) Guidance for industry and FDA reviewers. Immunotoxicity testing guidance (for medical devices and constituent materials)

    Google Scholar 

  46. Basketter DA, Gilmour NJ, Briggs D, Ullmann LG, Gerberick GF, Ryan CA, Dearman RJ, Kimber I (1993) Utility of historic vehicle-control data in the interpretation of the local lymph node assay. Contact Dermatitis 49:37–41

    Article  Google Scholar 

  47. Anderson SE, Siegel PD, Meade BJ (2011) The LLNA: a brief review of recent advances and limitations. J Allergy (Cairo) 2011:424203

    Google Scholar 

  48. Descotes J (1992) The popliteal lymph node assay: a tool for studying the mechanisms of drug-induced autoimmune disorders. Toxicol Lett 64–65.(Spec No:101–107

    Article  Google Scholar 

  49. Galbiati V, Papale A, Kummer E, Corsini E (2016) In vitro models to evaluate drug-induced hypersensitivity: potential test based on activation of dendritic cells. Front Pharmacol 7:204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Descotes J (1985) Pseudoallergic reactions of drug origin. Therapie 40:59–65

    PubMed  CAS  Google Scholar 

  51. Szebeni J, Muggia F, Gabizon A, Barenholz Y (2011) Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev 63:1020–1030

    Article  CAS  PubMed  Google Scholar 

  52. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K et al (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358:2457–2467

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A et al (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology biologics register (BSRBR). Ann Rheum Dis 69:522–528

    Article  CAS  PubMed  Google Scholar 

  54. Bloomgren G, Richman S, Hotemans C, Subramanyam M, Goelz S, Natarajan A et al (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870–1880

    Article  CAS  PubMed  Google Scholar 

  55. Hastings KL (2000) Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models. Hum Exp Toxicol 19:261–265

    Article  CAS  PubMed  Google Scholar 

  56. Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D et al (2007) “Cytokine storm” in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 179:3325–3331

    Article  CAS  PubMed  Google Scholar 

  57. Hastings KL (2007) Drug allergy. In: Luebke R, House R, Kimber I (eds) Immunotoxicology and immunopharmacology, 3rd edn. CRC Press, Taylor & Francis Group, Boca Raton, FL, pp 623–632

    Google Scholar 

  58. Azzi JR, Sayegh MH, Mallat SG (2013) Calcineurin inhibitors: 40 years later, can’t live without. J Immunol 191:5785–5791

    Article  CAS  PubMed  Google Scholar 

  59. Yanagida N, Sato S, Asaumi T, Ebisawa M (2016) Comparisons of outcomes with food immunotherapy strategies: efficacy, dosing, adverse effects, and tolerance. Curr Opin Allergy Clin Immunol 16:396–403

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hastings Toxicology Consulting LLC, Mount Airy, MD, USA

    Kenneth L. Hastings

Authors
  1. Kenneth L. Hastings
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pharmacology and Toxicology, East Carolina University, Greenville, North Carolina, USA

    Jamie C. DeWitt

  2. Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, USA

    Cheryl E. Rockwell

  3. Durham, North Carolina, USA

    Christal C. Bowman

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Hastings, K.L. (2018). Immunotoxicology: A Brief History. In: DeWitt, J., Rockwell, C., Bowman, C. (eds) Immunotoxicity Testing. Methods in Molecular Biology, vol 1803. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-8549-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-8549-4_1

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-8548-7

  • Online ISBN: 978-1-4939-8549-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation